Two papers published in The New England Journal of Medicine highlight the potential of gene editing for treatment of sickle ...
Learn about the groundbreaking gene therapy for sickle cell disease at Manning Family Children's Hospital in Louisiana, ...
Exagamglogene autotemcel (exa-cel), a CRISPR/Cas9 gene-edited cell therapy, eliminated vaso-occlusive crises in 97% of participants with severe sickle cell disease. The therapy led to substantial ...
As early results show promise, the 23-year-old hopes the treatment could finally clear a path toward his dream of becoming ...
RICHMOND, Va. — September is National Sickle Cell Awareness Month. Sickle cell affects 100,000 people in the United States, primarily impacting African Americans. To learn more about the genetic blood ...
Dr. Swee Lay Thein and Dr. Stuart Orkin won the $3 million Breakthrough Prize in Life Sciences for their work toward a ...
Sickle cell disease (SCD) is a group of genetic blood disorders. A person inherits SCD from their parents when they inherit two copies of the sickle cell gene, one from each parent. This hereditary ...
A new breakthrough study led by researchers at the University of Minnesota Twin Cities could explain why patients with the same genetic sickle cell mutation experience different levels of pain, organ ...
Within 12 hours of landing in Florida in January, 2021, Sebastien Beauzile, then 17, was admitted to two separate hospitals. He had come to Florida to surprise his sister for her birthday. But instead ...
Contrary to misconceptions among medical professionals and patients alike, individuals born with sickle cell trait (SCT) show no risk of experiencing the acute pain crises known to occur with sickle ...
Despite data gaps in many countries, the burden of sickle cell disease, especially in west and central Africa, underscores ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results